President and CEO of Exact Sciences Corp (NASDAQ:EXAS) Kevin T Conroy sold 123,512 shares of EXAS on 12/22/2017 at an average price of $52.58 a share. The total sale was $6.5 million.
Exact Sciences Corp operates in the healthcare sector. It is a diagnostics company focused on the early detection and prevention of colorectal cancer. Exact Sciences Corp has a market cap of $6.27 billion; its shares were traded at around $52.34 with and P/S ratio of 27.84. Exact Sciences Corp had annual average EBITDA growth of 18.60% over the past ten years.
CEO Recent Trades:
President and CEO Kevin T Conroy sold 123,512 shares of EXAS stock on 12/22/2017 at the average price of $52.58. The price of the stock has decreased by 0.46% since.President and CEO Kevin T Conroy sold 121,849 shares of EXAS stock on 12/06/2017 at the average price of $53.45. The price of the stock has decreased by 2.08% since.
Directors and Officers Recent Trades:
Chief Science Officer Graham Peter Lidgard sold 45,770 shares of EXAS stock on 12/01/2017 at the average price of $58.27. The price of the stock has decreased by 10.18% since.
For the complete insider trading history of EXAS, click here